Solid Biosciences (SLDB) Total Liabilities: 2017-2024
Historic Total Liabilities for Solid Biosciences (SLDB) over the last 7 years, with Sep 2024 value amounting to $44.8 million.
- Solid Biosciences' Total Liabilities rose 10.99% to $44.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $44.8 million, marking a year-over-year increase of 10.99%. This contributed to the annual value of $38.5 million for FY2023, which is 20.85% down from last year.
- As of Q3 2024, Solid Biosciences' Total Liabilities stood at $44.8 million, which was up 18.73% from $37.7 million recorded in Q2 2024.
- Solid Biosciences' 5-year Total Liabilities high stood at $48.6 million for Q4 2022, and its period low was $17.2 million during Q2 2020.
- Over the past 3 years, Solid Biosciences' median Total Liabilities value was $41.0 million (recorded in 2023), while the average stood at $40.4 million.
- In the last 5 years, Solid Biosciences' Total Liabilities tumbled by 38.16% in 2021 and then soared by 107.76% in 2023.
- Quarterly analysis of 5 years shows Solid Biosciences' Total Liabilities stood at $39.1 million in 2020, then crashed by 38.16% to $24.2 million in 2021, then skyrocketed by 101.03% to $48.6 million in 2022, then fell by 20.85% to $38.5 million in 2023, then increased by 10.99% to $44.8 million in 2024.
- Its Total Liabilities was $44.8 million in Q3 2024, compared to $37.7 million in Q2 2024 and $38.0 million in Q1 2024.